Welcome to gatalin.co.uk
Gatalin® XL is a prolonged-release capsule of galantamine indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.1
Available as:
Gatalin XL is bioequivalent to Reminyl® (galantamine) XL (Takeda).2
Gatalin XL could offer significant cost savings to your practice and clinical commissioning group (CCG).
Galantamine 8mg, 16mg and 24mg prolonged-release capsules are in category C of the UK Drug Tariff.3
However, the NHS can make 50% savings on the cost of category C galantamine by prescribing Gatalin XL by brand name.3*
Quite simply a wholesale switch of galantamine 8mg, 16mg and 24mg prolonged-release prescriptions to Gatalin XL could still save an average ICS/ICB £24,102 per year.4**
Gatalin XL is one of Aspire Pharma’s cost saving prolonged-release products.
In addition Gatalin XL:
*50% saving on the cost of Category C galantamine prolonged-release capsules in the UK Drug Tariff. **Savings based on market data in reference 4. For 42 ICS/ICBs switching their generic and originator brand 8mg, 16mg and 25mg galantamine prolonged-release capsule prescriptions to Gatalin XL. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review.
References: 1) Gatalin (galantamine) XL SmPCs. 2) 1010067149 v 6.0 September 2023 Data on File 3) February 2024 UK Drug Tariff. 4) Insypher GPPLPD Date Range: Jul-23 – Sep-23 10100831045 v 17.0 January 2024
For more information about Gatalin XL, please see the abbreviated prescribing information.